State Street’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.1M | Buy |
1,388,108
+16,611
| +1% | +$384K | ﹤0.01% | 1927 |
|
|
2025
Q1 | $37M | Buy |
1,371,497
+103,548
| +8% | +$2.8M | ﹤0.01% | 1806 |
|
|
2024
Q4 | $67.9M | Sell |
1,267,949
-93,229
| -7% | -$4.99M | ﹤0.01% | 1561 |
|
|
2024
Q3 | $61.8M | Sell |
1,361,178
-40,056
| -3% | -$1.82M | ﹤0.01% | 1597 |
|
|
2024
Q2 | $58.7M | Buy |
1,401,234
+1,001,767
| +251% | +$42M | ﹤0.01% | 1581 |
|
|
2024
Q1 | $15M | Buy |
399,467
+51,882
| +15% | +$1.95M | ﹤0.01% | 2338 |
|
|
2023
Q4 | $3.73M | Buy |
347,585
+16,014
| +5% | +$172K | ﹤0.01% | 3085 |
|
|
2023
Q3 | $3.34M | Sell |
331,571
-1,019
| -0.3% | -$10.3K | ﹤0.01% | 3108 |
|
|
2023
Q2 | $3.95M | Buy |
332,590
+33,961
| +11% | +$403K | ﹤0.01% | 3114 |
|
|
2023
Q1 | $3.61M | Buy |
298,629
+15,519
| +5% | +$188K | ﹤0.01% | 3113 |
|
|
2022
Q4 | $3.73M | Buy |
283,110
+18,903
| +7% | +$249K | ﹤0.01% | 3169 |
|
|
2022
Q3 | $3.58M | Buy |
264,207
+185
| +0.1% | +$2.51K | ﹤0.01% | 3220 |
|
|
2022
Q2 | $3.22M | Buy |
264,022
+22,024
| +9% | +$269K | ﹤0.01% | 3310 |
|
|
2022
Q1 | $3.47M | Buy |
241,998
+30,432
| +14% | +$436K | ﹤0.01% | 3345 |
|
|
2021
Q4 | $4.17M | Buy |
211,566
+36,922
| +21% | +$728K | ﹤0.01% | 3327 |
|
|
2021
Q3 | $3.78M | Buy |
+174,644
| New | +$3.78M | ﹤0.01% | 3378 |
|